Trial record 5 of 68 for:
Open Studies | "Urticaria"
Validation of an Urticaria Control Test (UCT-V)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Charite University, Berlin, Germany.
Recruitment status was Recruiting
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany
First received: June 6, 2012
Last updated: February 14, 2013
Last verified: February 2013
The aim of this study is to validate a previously developed patient reported outcome instrument (in project UCT-D) to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.
||Time Perspective: Prospective
||Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||August 2013 (Final data collection date for primary outcome measure)
chronic urticaria patients
all patients suffering from chronic forms of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)
|Ages Eligible for Study:
||12 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
all patients suffering from chronic forms of urticaria
all patients suffering from chronic forms of urticaria are eligible
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01614834
|Mainz, Rheinland-Pfalz, Germany, 55131 |
|Contact: Petra Staubach, MD firstname.lastname@example.org |
|Principal Investigator: Petra Staubach, MD |
|Berlin, Germany, 10117 |
|Contact: Karsten Weller, MD email@example.com |
|Principal Investigator: Karsten Weller, MD |
Charite University, Berlin, Germany
No publications provided
||K. Weller, Pricipal Investigator, Charite University, Berlin, Germany
History of Changes
|Other Study ID Numbers:
|Study First Received:
||June 6, 2012
||February 14, 2013
||Germany: Ethics Commission
Keywords provided by Charite University, Berlin, Germany:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 03, 2015
Immune System Diseases
Skin Diseases, Vascular